Effect of a specific endothelin receptor A antagonist on murine lupus nephritis and IgA nephropathy.
Ebihara
I
I
Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Nakamura
T
T
Tomino
Y
Y
Koide
H
H
D000818:Animals; D001381:Azepines / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000235:genetics; D005260:Female; D005922:Glomerulonephritis, IGA / Q000188:drug therapy*; D006023:Glycoproteins / Q000235:genetics; D007211:Indoles / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000473:pathology; D008181:Lupus Nephritis / Q000188:drug therapy*; D051379:Mice; D008813:Mice, Inbred ICR; D008814:Mice, Inbred NZB; D011507:Proteinuria / Q000188:drug therapy; D012333:RNA, Messenger / Q000032:analysis; D044022:Receptor, Endothelin A; D019714:Tissue Inhibitor of Metalloproteinases
D001381:Azepines; D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D006023:Glycoproteins; D007211:Indoles; D012333:RNA, Messenger; D044022:Receptor, Endothelin A; D019714:Tissue Inhibitor of Metalloproteinases; C079574:FR 139317